Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

840

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

October 31, 2031

Study Completion Date

October 31, 2031

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Livmoniplimab

Intravenously (IV) Infusion

DRUG

Budigalimab

IV Infusion

DRUG

Pembrolizumab

IV Infusion

DRUG

Pemetrexed

IV Infusion

DRUG

Cisplatin

IV Infusion

DRUG

Carboplatin

IV Injection

DRUG

Carboplatin

IV Infusion

Trial Locations (61)

104

RECRUITING

Mackay Memorial Hospital /ID# 262534, Taipei

333

RECRUITING

Linkou Chang Gung Memorial Hospital /ID# 262535, Taoyuan

704

RECRUITING

National Cheng Kung University Hospital /ID# 262016, Tainan City

1200

RECRUITING

Cliniques Universitaires UCL Saint-Luc /ID# 261267, Brussels

2145

RECRUITING

Westmead Hospital /ID# 261894, Westmead

2605

RECRUITING

Canberra Hospital /ID# 261891, Garran

2650

RECRUITING

Universitair Ziekenhuis Antwerpen /ID# 261270, Edegem

2747

RECRUITING

Nepean Hospital /ID# 262157, Kingswood

4000

RECRUITING

Groupe Sante CHC - Clinique du MontLegia /ID# 262338, Liège

5000

RECRUITING

UCL Namur University Hospital, Site Sainte-Elisabeth /ID# 262557, Namur

7100

RECRUITING

Hospital La Louviere Site Jolimont - Helora /ID# 261269, La Louvière

9000

RECRUITING

AZ Maria Middelares /ID# 262313, Ghent

11031

RECRUITING

Taipei Medical University Hospital /ID# 262020, Taipei

13015

RECRUITING

APHM - Hopital Nord /ID# 261129, Marseille

15706

RECRUITING

Complejo Hospitalario Universitario de Santiago (CHUS) /ID# 262723, Santiago de Compostela

18840

RECRUITING

Guthrie Robert Packer Hospital /ID# 262758, Sayre

28007

RECRUITING

Hospital General Universitario Gregorio Maranon /ID# 262114, Madrid

28041

RECRUITING

Hospital Universitario 12 de Octubre /ID# 262112, Madrid

30607

RECRUITING

University Cancer & Blood Cent /ID# 261824, Athens

33028

RECRUITING

Memorial Hospital West /ID# 262221, Pembroke Pines

33880

RECRUITING

Bond Clinic /ID# 262611, Winter Haven

35110

RECRUITING

Dr. Suat Seren Gogus Has /ID# 261789, Izmir

38700

RECRUITING

CHU Grenoble - Hopital Michallon /ID# 261131, La Tronche

40503

RECRUITING

Baptist Health Lexington /ID# 261823, Lexington

45252

RECRUITING

Oncology Hematology Care, Inc - Blue Ash /ID# 262733, Cincinnati

46010

RECRUITING

Hospital Clinico Universitario de Valencia /ID# 262115, Valencia

63110

RECRUITING

Washington University-School of Medicine /ID# 262759, St Louis

66205

RECRUITING

University of Kansas Medical Center /ID# 263196, Westwood

69500

RECRUITING

Hospices Civils de Lyon (HCL) - Hopital Louis Pradel /ID# 261644, Bron

75075

RECRUITING

Texas Oncology - Plano East /ID# 264356, Plano

75248

RECRUITING

Institut Curie /ID# 261127, Paris

77030

RECRUITING

Houston Methodist Hospital /ID# 262722, Houston

78240

RECRUITING

Texas Oncology - San Antonio Medical Center - Research Drive /ID# 264311, San Antonio

91031

RECRUITING

Shaare Zedek Medical Center /ID# 262432, Jerusalem

92037

RECRUITING

Moores Cancer Center /ID# 267782, La Jolla

94000

RECRUITING

Centre Hosp Intercommunal de Creteil /ID# 261130, Créteil

2520598

RECRUITING

Sociedad Cem-Cancer Spa /Id# 262316, Viña del Mar

3109601

RECRUITING

Rambam Health Care Campus /ID# 262431, Haifa

4810218

RECRUITING

Centro de Investigacion y Desarrollo Oncologico /ID# 261800, Temuco

7500921

RECRUITING

Fundacion Arturo Lopez Perez /ID# 261700, Providencia

7501504

RECRUITING

Hospital Clinico Universidad De Los Andes /ID# 262665, Santiago

7650027

RECRUITING

Oncored /Id# 261801, Vitacura

60637-1443

RECRUITING

The University of Chicago Medical Center /ID# 262259, Chicago

49546-7062

RECRUITING

Cancer & Hematology Centers of Western Michigan - East /ID# 261826, Grand Rapids

11794-0001

RECRUITING

Stony Brook Cancer Center /ID# 261954, Stony Brook

27403-1109

RECRUITING

Cone Health Cancer Center /ID# 262583, Greensboro

79915-1803

COMPLETED

Renovatio clinical /ID# 262000, El Paso

77380-3181

COMPLETED

Renovatio Clinical /ID# 261999, The Woodlands

98506-5028

RECRUITING

Vista Oncology - East Olympia /ID# 262303, Olympia

277-8577

RECRUITING

National Cancer Center Hospital East /ID# 261923, Kashiwa-shi

362-0806

RECRUITING

Saitama Cancer Center /ID# 262703, Kitaadachi-gun

104-0045

RECRUITING

National Cancer Center Hospital /ID# 261925, Chuo-ku

3844 DG

RECRUITING

Ziekenhuis St. Jansdal /ID# 261193, Harderwijk

6419 PC

RECRUITING

Zuyderland Medisch Centrum /ID# 261190, Heerlen

8025 AB

RECRUITING

Isala /ID# 262458, Zwolle

00935

RECRUITING

Pan American Center for Oncology Trials /ID# 269666, Rio Piedras

08907

RECRUITING

Institut Català d'Oncologia (ICO) - L'Hospitalet /ID# 262118, L'Hospitalet de Llobregat

08017

RECRUITING

UOMi Cancer Center - Clinica Tres Torres /ID# 262116, Barcelona

08035

RECRUITING

Hospital Universitario Vall d'Hebron /ID# 262113, Barcelona

06560

RECRUITING

Gazi University Medical Faculty /ID# 261786, Ankara

06800

RECRUITING

Ankara City Hospital /ID# 261785, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY

NCT06236438 - Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter